A novel method for quantitation of AAV genome integrity using duplex digital PCR

Area of Science:

• Molecular Biology
• Bioinformatics
• Gene Therapy

Background:

• Recombinant adeno-associated virus (rAAV) vectors are key for gene therapy delivery.
• Heterogeneity in rAAV capsid content necessitates precise characterization methods.
• Accurate assessment of rAAV efficacy and safety relies on robust analytical tools.

Purpose of the Study:

• To develop a novel statistical model for estimating genome integrity from duplex digital PCR (dPCR) assays.
• To address the scarcity of accurate analytical tools for multiplexed dPCR data in rAAV characterization.
• To improve the accuracy and quantifiable range of duplex dPCR assays for rAAV analysis.

Main Methods:

• Development of a novel statistical model based on a Poisson-multinomial mixture distribution.
• Application of the model to analyze duplex digital PCR (dPCR) data for rAAV genome integrity.
• Comparison of the novel model's performance against existing analytical approaches.

Main Results:

• The proposed Poisson-multinomial mixture model significantly enhances the accuracy of duplex dPCR assays.
• The model expands the quantifiable range for assessing rAAV genome integrity.
• Demonstrated superior performance compared to current models for multiplexed dPCR data analysis.

Conclusions:

• The novel statistical model provides a more accurate and reliable method for rAAV genome integrity estimation.
• This advancement is critical for improving the quality control of rAAV-based gene therapies.
• The developed model addresses a significant gap in the analytical tools available for rAAV characterization.